Abstract Details

Title Early Clinical Development of GNBAC1 a Humanized Monoclonal Antibody Neutralizing MSRV-ENV, a Neurotoxic Protein, for the Treatment of Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 076

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Herve Perron, PhD	Mr. Perron has received personal compensation for serving as an employee of Geneuro-Innovation. Mr. Perron has stock in GeNeuro. The institution of Mr. Perron has received research support from European Union (EU) HORIZON HEALTH Program.
	No disclosure on file
	No disclosure on file
Francois Curtin	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��